THE DOSE
your daily dose of Innovative, trending, and groundbreaking stories from across the cosmos.
Atai's Strategic Move: Investing in Beckley Psytech for Rapid-Acting Psychedelic Medicines
In an unprecedented move, Atai Life Sciences, a global biotech company, has invested a significant amount in Beckley Psytech, a company specializing in psychedelic medicine. This strategic investment marks a monumental step towards the development of rapid-acting psychedelic medicines, signifying a potential paradigm shift in mental health treatment.
The Oregon Psychedelic Industry Begins
With The regulatory framework of measure 109 now in place, the start of 2023 means that Oregon is beginning to accept applications for licenses to operate in the new psychedelic industry.
TripSitter Plans Virtual Mental Health Clinics
TripSitter Clinic Corp is an international psychedelic medicine and telehealth company enabling physician directed safe and legal entheogen treatment plans. They are currently developing virtual health clinics to help with monitoring, and coaching with patients and licensed physicians. They have recently teamed up in medical, clinical, and administrative operations with Insight Systems, PBC dba Reconscious Medical, which is a psychedelic psychotherapy company engaging in both in-clinic and online virtual care with safety, monitoring, and support provided through a proprietary technology platform.
SykoActive News Updates
Today the hot news is that Ecstasy and psilocybin are shaking up psychiatry with psychedelic Therapy Schools Popping Up everywhere like little Magic Mushrooms! In addition to recently announced Hawaii, New Psychedelic Bills are being filed in Florida, Connecticut, Vermont and New Jersey, as the freedom of consciousness and natural medicine movement sweeps the globe.
Cybin Becomes The Heavy Hitter In The Psychedelic Industry
In the past 12 months, Cybin has expanded the psychedelic organization to more than 55 employees across four countries and has established partnerships with over 50 participants in the psychedelic industry.
Detroit Just Decriminalized Psychedelics
Detroit has joined the growing number of cities and states that have decriminalized entheogenic plants and fungi, known as “magic mushrooms” and psychedelics. Voters, including the city’s incumbent mayor who won a re-election, passed Proposal E on Tuesday night to decriminalize entheogenic plants and fungi.
The Psychedelics Science Funders Collaborative Guides Investors In The Right Direction
The Psychedelic Science Funders Collaborative or PSFC is leading the community of philanthropists funding psychedelic research and supporting psychedelic medicine. PSFC identifies and assesses funding opportunities for its members, provides ongoing support for its funding partners, and facilitates relationships and education about psychedelic research within the philanthropic community.
Pharmadrug Files for FDA Orphan Drug Destination for DMT Treatments
Pharmadrug is a specialty pharmaceutical company involved in the research, development, and commercialization of controlled substances and all-natural medicines including psychedelics like DMT, cannabis, and naturally occurring drug derivatives.
Mydecine Innovations Group Public Offering led by Canaccord Genuity Corp.
As an emerging BioPharma and life sciences company, Mydecine is currently researching and developing alternative natural medicines and constructing a drug pipeline for the psychedelic industry. Bought stock offering with Canaccord will increase Mydecine capital by almost 20 million dollars!
Transcend Into The Fractal World
Tripping on Psychedelics wouldn't be the same without the "Founder of the Fractal world", Benoit Mandelbrot.
Ann Arbor is 3rd U.S. City to Decriminalized Entheogens
Ann Arbor’s City Council unanimously passed the resolution after a campaign organized by Decriminalize Nature Ann Arbor, which had support from the board of directors of Decriminalize Nature. The resolution is adapted from the Decriminalize Nature resolution that passed in Oakland in 2019 and follows a trend of decriminalizing psychedelic substances for breakthrough therapy treatments focused on treating mental and emotional health issues.